Cancer combinatorial immunotherapy using anti-OX40 agonist and anti-PD-L1 antagonist: a patent evaluation of US2018256711A1
Article in Expert Opinion on Therapeutic Patents (June 2019)
The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.
Article in Expert Opinion on Therapeutic Patents (June 2019)
Article in International Journal of Molecular Sciences (March 2019)